{
  "meta": {
    "id": "test87",
    "title": "Targeted Therapy",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Among the following options, the first monoclonal antibody to be approved for the treatment of breast cancer is?",
      "options": [
        {
          "label": "A",
          "text": "Cetuximab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rituximab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Trastuzumab",
          "correct": true
        },
        {
          "label": "D",
          "text": "Alemtuzumab",
          "correct": false
        }
      ],
      "correct_answer": "C. Trastuzumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Trastuzumab Trastuzumab is used to treat certain types of breast or stomach cancer, sometimes combined with other cancer medicines. trastuzumab is sometimes used when the cancer has spread to other parts of the body (metastatic).</p>\n<p><strong>Highyeild:</strong></p><p>Trastuzumab was the first monoclonal antibody to be approved for the treatment of a solid tumor a humanized monoclonal antibody that binds to the external domain of HER2/neu used for HER2/neu-overexpressing metastatic breast cancer, in combination with paclitaxel as initial treatment or as monotherapy following chemotherapy relapse Trastuzumab is indicated in early stage HER2 positive but ER/PR negative carcinoma breast that has spread to the lymph node. It is also useful in HER2 overexpressing gastric carcinoma. Trastuzumab is generally used along with taxanes or may be used alone in relapse cases. The specific toxicity is a decrease in LVEF and cardiomyopathy which may lead to CHF in ~1% of Monitoring of LVEF is recommended</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. cetuximab is used in the treatment of head and neck cancer and cancer of the colon and rectum. It helps to mark the cancer cells for destruction by the body's immune system. Option: B. Rituximab is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis, and microscopic polyangiitis. Option: D . Alemtuzumab is used in the treatment of blood cancer (chronic lymphocytic leukemia) and multiple sclerosis (MS). It marks the cancer cells for destruction by the body's immune system. It also modulates the immune system to limit its attacks on the nervous system.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29b6e4cc",
      "audio": ""
    },
    {
      "text": "Sipuleucel-T is used in the treatment of which of the following condition?",
      "options": [
        {
          "label": "A",
          "text": "AML",
          "correct": false
        },
        {
          "label": "B",
          "text": "Breast cancer",
          "correct": false
        },
        {
          "label": "C",
          "text": "Prostate cancer",
          "correct": true
        },
        {
          "label": "D",
          "text": "Multiple myeloma",
          "correct": false
        }
      ],
      "correct_answer": "C. Prostate cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Prostate cancer Sipuleucel-T: is a cell-based approach designed to induce an immune response against PAP, which is expressed in most prostate cancers</p>\n<p><strong>Highyeild:</strong></p><p>Sipuleucel-T Sipuleucel-T is a cell-based approach designed to induce an immune response against PAP, which is expressed in most prostate cancers. This autologous cellular immunotherapy is generated from a patient\u2019s peripheral blood cells, isolated by leukapheresis. The cells are exposed to a human recombinant protein, PAP\u2013GM-CSF. APCs present in the blood cells are thought to take up and process PAP and direct the immune response toward the antigen. A patient receives the treated cells by infusion on three occasions at 2-week intervals.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Acute myeloid leukemia ( AML ) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. Symptoms may include tiredness, shortness of breath, easy bruising and bleeding, and increased risk of infection. Option: B.Breast cancer: Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with a distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin. Option: D . multiple myeloma cancer of mature plasma cells in the bone marrow. This causes bone pain in the chest or spine, fatigue, nausea, constipation, frequent infections, and weight loss.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "67d134cb",
      "audio": ""
    },
    {
      "text": "Treatment of choice for Glioblastoma multiforme is?",
      "options": [
        {
          "label": "A",
          "text": "Atezolizumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carboplatin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Paclitaxel",
          "correct": false
        },
        {
          "label": "D",
          "text": "Temozolomide",
          "correct": true
        }
      ],
      "correct_answer": "D. Temozolomide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Temozolomide Temozolomide is used in the treatment of specific types of cancer of the brain. It is used to treat brain tumors if they return or get worse after standard treatment. It may be also used to treat other conditions, as determined by the doctor.</p>\n<p><strong>Highyeild:</strong></p><p>Glioblastoma multiforme: Single-agent chemotherapy with radiation therapy: Temozolomide Temozolomide: This orally active triazine methylating agent is the drug of choice for glioma and other malignant brain tumors; also utilized in melanoma. Adverse effects are similar to dacarbazine</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: C. Paclitaxel is used to treat breast cancer ovarian cancer and non-small lung cancer. Option: B. Carbonation is used to treat cancer of the It includes the type of chemotherapy Option: A. Atezolizumab is used after surgery and platinum chemotherapy in adults with stage IIA, stage IIB or Stage IIIA cancer that has the PD-L, protein. It is called kinase inhibitors.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3af5fc7e",
      "audio": ""
    },
    {
      "text": "Among the following options, the Treatment of choice for Hepatocellular carcinoma is?",
      "options": [
        {
          "label": "A",
          "text": "Dacarbazine,",
          "correct": false
        },
        {
          "label": "B",
          "text": "Temozolomide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sorafenib",
          "correct": true
        },
        {
          "label": "D",
          "text": "Imatinib",
          "correct": false
        }
      ],
      "correct_answer": "C. Sorafenib",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Sorafenib Hepatocellular carcinoma Single-agent chemotherapy: Sorafenib other drugs:Doxorubicin, regorafenib</p>\n<p><strong>Highyeild:</strong></p><p>Sorafenib: Another orally active synthetic VEGF receptor tyrosine kinase inhibitor that, like sunitinib, inhibits several other tyrosine kinases as well. It is indicated in advanced/metastatic renal cell carcinoma as a second-choice drug to sunitinib. In addition, sorafenib is approved for hepatocellular cancer as well as for progressive/metastatic papillary carcinoma of the thyroid that is refractory to radioactive iodine.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Dacarbazin e- is used in chemotherapy medication for melanoma and Hodgkin\u2019s lymphoma. Option: B. Temozolomide- is used in the treatment of specific types of brain cancer Option: D.Imatinib is used to treat CML, GIST, and a number of other malignancies</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3d28980a",
      "audio": ""
    },
    {
      "text": "Among the following options, \u2018Hand Foot\u2019 syndrome can be caused by?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vincristine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Capecitabine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mitomycin-C",
          "correct": false
        }
      ],
      "correct_answer": "C. Capecitabine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Capecitabine Capecitabine, is used in the treatment of cancer of the breast, colon, and rectum. It may be also used to treat other conditions, as determined by the doctor.</p>\n<p><strong>Highyeild:</strong></p><p>Capecitabine This is an orally active prodrug of 5-FU. After absorption, it is converted to deoxy-5-fluorouridine in the liver and released in the Taken up by cells, it is hydrolyzed to 5-FU by thymidine phosphorylase. Because many breast and colorectal cancer cells express large quantities of this enzyme, they generate more 5-FU and suffer higher toxicity than normal cells. A combined regimen of capecitabine + oxaliplatin is frequently used in metastatic colorectal cancer. Hand-foot syndrome and diarrhea are prominent adverse effects, but bone marrow depression and mucositis are less marked.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A:Side effect of methotrexate Hepatic cirrhosis Leukopenia Thrombocytopenia Anaemia including aplastic anomia Interstitial periodontitis Stomatitis Alopecia Option D: Side effects of mitomycin- C Delayed and prolonged myelosuppression Lung fibrosis Option B: Side effect of vincristine Alopecia more common Peripheral and autonomic neuropathy & muscle weakness Constipation</p>\n<p><strong>Extraedge:</strong></p><p>Adjuvant Capecitabine in Older Breast Cancer Patients The largest randomized trial to date in elderly patients with early-stage breast cancer found no benefit in invasive disease-free survival for use of monotherapy with capecitabine, the study combined capecitabine with ibandronate and compared that combination with ibandronate alone. Although capecitabine is often used in the metastatic setting for elderly patients because it is thought to be less toxic than chemotherapy, this study showed there was no role for capecitabine monotherapy in the treatment of early-stage breast cancer in older patients.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "488352f7",
      "audio": ""
    },
    {
      "text": "ATRA is useful in the treatment of which of the following type of AML?",
      "options": [
        {
          "label": "A",
          "text": "Monocytic leukemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Myelomonocytic leukemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Promyelocytic leukemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Erythroleukemic leukemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Promyelocytic leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Promyelocytic leukemia Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. Symptoms may include feeling tired, shortness of breath, easy bruising, and bleeding.</p>\n<p><strong>Highyeild:</strong></p><p>Treatment of promyelocytic leukemia is by tretinoin . (ATRA ) It is an oral drug that induces the differentiation of leukemia cells bearing the t (15,17) It is not effective in other forms of AML.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. monocytic leukemia, Acute monocytic leukemia is a type of acute myeloid leukemia. In AML-M5 >80% of the leukemic cells are of monocytic lineage. This cancer is characterized by a dominance of monocytes in the bone marrow. Option: B. Chronic myelomonocytic leukemia (CMML) starts in blood-forming cells in the bone marrow and invades the blood. Cells in nearly any part of the body can become cancerous and can spread to other areas of the body. Option: D. Acute erythrocyte leukemia is a rare form of acute myeloid leukemia (less than 5% of AML cases ) where the myeloproliferative is of erythrocytic precursors. It is defined as type \"M6\" under the FAB classification.</p>\n<p><strong>Table:</strong></p><p>WHO\nclassification of AML AML with recurrent\n     cytogenetic abnormalities t(8;21) inv(16) Acute\n      promyelocytic leukemia - 1(15;17) and variants AML with\n      11q23 (MLL gene) abnormalities AML with\n     multilineage dysplasia AML/MDS,\n     therapy-related AML not\n     otherwise categorized Minimally\n      differentiated Without\n      maturation With\n      maturation Acute\n      myelomonocytic leukemia Acute\n      monoblastic and monocytic leukemia Acute\n      erythroid leukemia Acute\n      megakaryblastic leukemia Acute\n      basophilic leukemia Acute\n      panmyelosis with myelofibrosis Myeloid\n      sarcoma AML with\n     ambiguous lineage Undifferentiated\n      AML Bilineal\n      AML Biphenotypic\n      AML</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "60662e70",
      "audio": ""
    },
    {
      "text": "Leucovorin is used as Rescue therapy for patients who are on one of the following drug therapies:",
      "options": [
        {
          "label": "A",
          "text": "Asparagine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Methotrexate",
          "correct": true
        },
        {
          "label": "C",
          "text": "6-mercaptopurine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cyclophosphamide",
          "correct": false
        }
      ],
      "correct_answer": "B. Methotrexate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Methotrexate Methotrexate, is a medicine used to treat rheumatoid arthritis where it can prevent further joint damage. It is also used to treat severe forms of a skin disease called psoriasis by killing cells in the skin which are growing too quickly and to treat tumors in a range of cancers.</p>\n<p><strong>Highyeild:</strong></p><p>Methotrexate toxicity : Folinic acid (Leucovorin, citrovorum factor), is an active coenzyme form that does not need to be reduced by DHFRase before it can act. Methotrexate is a DHFRase inhibitor; its toxicity is not counteracted by folic acid, but antagonized by folinic acid. Folinic acid is expensive and not needed for the correction of simple folate deficiency for which folic acid is good enough.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Toxicity Amelioration 1 Folinic acid - Mtx. 2  Meena | Acetyl cysteine - Cyclophosphamide 3  SHT 3 antagonist\u27f6 PONU 4 Anthracycline\u27f6  Dexrazoxone 5 Amifostine \u2192 Ces flatin 6 Hypeneskeria \u2192 iv Allopurinol contro steword. 7 Thalidomide \u2192  ENL 8 Hypercalcemia \u2192  I.v bisphosphonate</p>\n<p><strong>Table:</strong></p><p>Coumadin ..Vitamin\n  K Benzodiazepines.. Romazicon\n  (Flumazenil) Magnesium\n  Sulfate. Calcium\n  Gluconate Heparin Protamine\n  Sulfate Tylenol Mucomyst Opiates Narcotic\n  analgesics, heroin morphine, Narcan Cholinergic\n  Meds Atropine,\n  pralidoxime (2-PAM) Digoxin Digiband Acetaminophen n-Acetylcysteine Iron Deferoxamine Alcohol\n  Withdrawal.. Librium Anticholinergics Physostigmine Beta\n  Blockers. Glucagon Methotrexate Leucovofin Anticoagulants Vitamin\n  K, FFP Aspirin Sodium\n  bicarbonate CCB Calcium,\n  glucagon, insulin Cyanide Tydroxycobalamin,\n  sodium thiosulfate Hydrofluoric\n  acid Calcium\n  Gluconate Insulin Glucose Isoniazid Deferoxamine Methanol Ethanol Ethylene\n  glycol. Fomepizole,\n  ethanol Methemoglobin Methylene\n  blue Tricyclic\n  antidepressant Sodium\n  bicarbonate</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cdef2929",
      "audio": ""
    },
    {
      "text": "Which of the following is the most common adverse reaction associated with cyclosporine therapy?",
      "options": [
        {
          "label": "A",
          "text": "Cardiotoxicity and hepatotoxicity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatotoxicity and nephrotoxicity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypotension and pulmonary fibrosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nephrotoxicity and infection risk",
          "correct": true
        }
      ],
      "correct_answer": "D. Nephrotoxicity and infection risk",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Nephrotoxicity and infection risk Nephrotoxicity ; occurs in about 8 of 10 patients receiving cyclosporine. It is typically dose-dependent and, particularly in renal transplant patients, could be due to either the drug (too much) or rejection. Infection occurs about as often as renal dysfunction .</p>\n<p><strong>Highyeild:</strong></p><p>As cyclosporine enters the body, it suppresses T-cell function. Reducing T-cell function will enable successful transplantation since T cells purpose of function is to kill off objects viewed as foreign. Cyclosporine reduces the T cell function without affecting B cell function and the production of antibodies. Therefore, suppressing T-cell function allows for the transplanted organ to be accepted without a problem. Not all organ transplants will be rejected by the body. However, cyclosporine is used as precautionary measures .</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Side effect cyclosporine- Hirsutism Gingival hyperplasia Hypercholesterolemia Tacrolimus Alopecia Neurotoxicity Pancreatic islet cell Toxicity leading to glucose intolerance GI disturbances</p>\n<p><strong>Extraedge:</strong></p><p>The common side effect of both: Cyclosporine and tacrolimus Nephrotoxicity HTN GOUT Hyperkalaemia Hypomagnesemia</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "034b0990",
      "audio": ""
    }
  ]
}